Utility of photodynamic diagnosis plus reflectance confocal microscopy in detecting the margins of extramammary Paget disease

Reflectance confocal microscopy of mammary Paget disease

Mammary Paget disease is the intraepidermal adenocarcinoma of the nipple area which is characterized usually by a well-demarcated eczematous plaque. Reflectance confocal microscopy (RCM), is an in vivo noninvasive diagnostic tool with a high-resolution imaging of the skin, almost comparable to conventional histology. RCM findings of Paget disease are limited in the literature. Most of the repor...

Reflectance Confocal Microscopy for Diagnosis of Mammary Paget's Disease.

Difficult-to-diagnose facial melanomas: Utility of reflectance confocal microscopy in uncovering the diagnosis

LM: Lentigo maligna pAK: pigmented actinic keratosis RCM: reflectance confocal microscopy M elanoma on sun-damaged skin, commonly known as lentigo maligna (LM, akin to melanoma in situ) and lentigo maligna melanoma (akin to invasive melanoma), is mostly found on the head and neck of elderly patients. This type of melanoma, particularly when found early, may be difficult to diagnose on clinical ...

[Reflectance confocal microscopy in the diagnosis of cutaneous melanoma].

Skin melanoma is an international public health issue, with a considerable increase in frequency over the past few years. Early diagnosis and excision are essential for good patient prognosis. Over the past two decades dermoscopy has gained significance due to a major improvement in the accuracy of skin melanoma diagnosis in its early stage. However, there are some benign lesions of questionabl...

In Vivo Diagnosis of Skin Cancer through Reflectance Confocal Microscopy

In vivo reflectance confocal microscopy (RCM) is an FDA approved non-invasive optical imaging technique that provides high-resolution cellular images of the skin. This new technology assists the dermatologist in the early diagnosis of skin cancers, thereby reducing the number of unnecessary biopsies performed and improving the malignant to benign biopsy ratio. In 2016, this new technology was a...